Treatment outcomes of intravitreal ranibizumab for diabetic macular oedema in vitrectomised eyes

被引：0
|
作者：
Lu, Vicky Hsin-Ju [1 ]
Antao, Sheelah [1 ]
Fajgenbaum, Mark [1 ,2 ]
Wong, Roger [2 ]
Bainbridge, James W. B. [1 ]
da Cruz, Lyndon [1 ]
Hamilton, Robin D. [1 ]
Rajendram, Ranjan [1 ]
机构：
[1] Moorfields Eye Hosp NHS Trust, Med Retina, London, England
[2] Kings Coll London, Dept Ophthalmol, St Thomas Hosp Campus, London, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2095
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Intravitreal fluocinolone acetonide (Iluvien) for treatment of refractory diabetic macular oedema in vitrectomised eyes
    A Kumar
    Q Alfahad
    A Mitra
    S Elsherbiny
    P L Lip
    Eye, 2016, 30 : 763 - 764
  • [2] Intravitreal Ranibizumab for the Treatment of Diabetic Macular Oedema
    Zacharaki, Fani
    Chandran, Manju
    Menon, Geeta
    OPHTHALMOLOGICA, 2014, 232 : 26 - 26
  • [3] Impact of vitrectomy on outcomes of treatment for diabetic macular oedema with intravitreal ranibizumab
    Antao, Sheelah
    Fajgenbaum, Mark
    Patrao, Namritha Valerie
    Wong, Roger
    da Cruz, Lyndon
    Bainbridge, James W. B.
    Rajendram, Ranjan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [4] Intravitreal ranibizumab for diabetic macular oedema in previously vitrectomized eyes
    Laugesen, Caroline Schmidt
    Ostri, Christoffer
    Brynskov, Troels
    Lund-Andersen, Henrik
    Larsen, Michael
    Vorum, Henrik
    Sorensen, Torben L.
    ACTA OPHTHALMOLOGICA, 2017, 95 (01) : 28 - 32
  • [5] Intravitreal fluocinolone acetonide (Iluvien) for treatment of refractory diabetic macular oedema in vitrectomised eyes (vol 30, pg 763, 2016)
    Kumar, A.
    Alfahad, Q.
    Mitra, A.
    Elsherbiny, S.
    Lip, P. L.
    EYE, 2016, 30 (05) : 770 - 770
  • [6] Improvement of Fixation in Diabetic Macular Oedema Patients under Intravitreal Ranibizumab Treatment
    Seidensticker, F.
    Reznicek, L.
    Cserhati, S.
    Liegl, R. G.
    Langer, J.
    Wolf, A.
    Kampik, A.
    Ulbig, M.
    Haritoglou, C.
    Kernt, M.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2013, 230 (05) : 524 - 529
  • [7] Iluvien monotherapy for diabetic macular oedema in vitrectomised and non-vitrectomised eyes: one year data
    Hawrami, A.
    Laviers, H.
    Patra, S.
    Zambarakji, H.
    ACTA OPHTHALMOLOGICA, 2016, 94
  • [8] COMPARISON OF INTRAVITREAL AFLIBERCEPT, RANIBIZUMAB AND DEXAMETHASONE IMPLANT IN EYES WITH PERSISTENT DIABETIC MACULAR OEDEMA DESPITE PRIOR BEVACIZUMAB TREATMENT
    Spooner, Kimberly
    Hong, Thomas
    Chang, Andrew
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 46 : 120 - 120
  • [9] Real-world outcomes of Ranibizumab treatment for Diabetic Macular Oedema
    Patrao, Namritha Valerie
    Antao, Sheelah
    Sim, Dawn A.
    Sivaprasad, Sobha
    Andrews, Richard
    Hamilton, Robin
    Egan, Catherine A.
    Tufail, Adnan
    Hykin, Philip G.
    Rajendram, Ranjan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [10] Microperimetry and mfERG as functional measurements in diabetic macular oedema undergoing intravitreal ranibizumab treatment
    Ana Rita Santos
    Miguel Raimundo
    Dalila Alves
    Marta Lopes
    Sérgio Pestana
    João Figueira
    José Cunha-Vaz
    Rufino Silva
    Eye, 2021, 35 : 1384 - 1392
12345